Table 5.
Multivariate Analysis of HAI titers (transformed into log2) by patients' characteristics.
| Variable | Category | B | CI95 | p | |
|---|---|---|---|---|---|
| H1N1 | HAI Pre- Vaccination | .794 | .573 to 1.015 | <.001 | |
| ALC | .001 | .000 to .001 | .029 | ||
| Sampling Time Interval | −.015 | −.029 to -.001 | .036 | ||
| H3N2 | HAI Pre- Vaccination | .758 | .571 to .944 | <.001 | |
| Malignancy | Hematological Solid | .562 | .098 to 1.026 | .018 | |
| ANC | −.000 | −.000 to −.000 | .035 | ||
| B | HAI Pre- Vaccination | .895 | .699 to 1.091 | <.001 | |
| Malignancy | Hematological Solid | .734 | .249 to 1.219 | .004 |
Dependent variable: Post vaccination Hemagglutination-Inhibition antibody titers (HAI) transformed into log2, ALC: Abs`olute Lymphocytes Count, ANC: Absolute Neutrophils Count, CI95: 95% Confidence Interval for B (B: coefficient).